Cargando…
Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
BACKGROUND: Alzheimer’s Disease (AD) affects millions globally, but therapy development is lagging. New experimental systems that monitor neuronal functions in conditions approximating the AD brain may be beneficial for identifying new therapeutic strategies. METHODS: We expose cultured neurons to a...
Autores principales: | Hsieh, Yi-Chen, Negri, Joseph, He, Amy, Pearse, Richard V., Liu, Lei, Duong, Duc M., Chibnik, Lori B., Bennett, David A., Seyfried, Nicholas T., Young-Pearse, Tracy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494921/ https://www.ncbi.nlm.nih.gov/pubmed/36131294 http://dx.doi.org/10.1186/s13024-022-00558-4 |
Ejemplares similares
-
Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2010) -
Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019) -
Secondary ganglioside GM2 accumulation in mucopolysaccharidoses
por: Sandhoff, Konrad
Publicado: (2021) -
Ganglioside GM2: a potential biomarker for cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2020)